Articles by Chris Burgess - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Chris Burgess

Chris Burgess


Chris Burgess, PhD, is an analytical scientist at Burgess Analytical Consultancy Limited, Rose Rae, The Lendings, Startforth, Barnard Castle, Co Durham, DL12 9AB, UK; Tel: +44 1833 637 446; chris@burgessconsultancy.com; www.burgessconsultancy.co

Articles
Calibration of instruments: Is Your UV Spectrometer Accurate Enough
January 2, 2014

This article takes a statistical look at the calibration requirements for a UV spectrometer.

The Basics of Measurement Uncertainty in Pharma Analysis
September 2, 2013

How good is a reportable value?

Evaluating Risk-Based Specifications for Pharmaceuticals
July 2, 2013

The author discusses the purpose of analysis and testing and the implications for specifications and their underlying statistical distribution.

Rounding Results for Comparison with Specification
April 2, 2013

The mysteries of rounding are exposed; strict, unbiased rounding can be applied.

Calculating the Reportable Result from Retest Data
February 2, 2013

Two methods to evaluate retest data following out-of-specification results.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
25%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
36%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here